(Q33365034)

English

Gemcitabine combined with oxaliplatin (GEMOX) as second-line chemotherapy in patients with advanced ovarian cancer refractory or resistant to platinum and taxane

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Gemcitabine combined with oxaliplatin (GEMOX) as second-line chemotherapy in patients with advanced ovarian cancer refractory or resistant to platinum and taxane (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Francesco Raspagliesi

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Flavia Zanaboni

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Francesca Vecchione

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Francesco Hanozet

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Paolo Scollo

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Antonino Ditto

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Barbara Grijuela

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rosanna Fontanelli

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Eugenio Solima

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Gianbattista Spatti

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Giuseppe Scibilia

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Shigeki Kusamura

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

67

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

5-6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

376-381

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Second-line treatment of ovarian cancer

1 reference

https://api.crossref.org/works/10.1159%2F000082921

21 January 2018

Gemcitabine in the treatment of ovarian cancer

1 reference

https://api.crossref.org/works/10.1159%2F000082921

21 January 2018

Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1159%2F000082921

21 January 2018

Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study

1 reference

https://api.crossref.org/works/10.1159%2F000082921

21 January 2018

Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study.

1 reference

https://api.crossref.org/works/10.1159%2F000082921

21 January 2018

Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1159%2F000082921

21 January 2018

Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin +/- taxane-pretreated ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1159%2F000082921

21 January 2018

A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy

1 reference

https://api.crossref.org/works/10.1159%2F000082921

21 January 2018

Phase II trial of weekly single-agent paclitaxel in platinum/paclitaxel-refractory ovarian cancer.

1 reference

https://api.crossref.org/works/10.1159%2F000082921

21 January 2018

Identifiers

10.1159/000082921

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

release_ei4pao75hreixhky7e4m6c43xa

1 reference

https://api.fatcat.wiki/v0/release/ei4pao75hreixhky7e4m6c43xa

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33365034&oldid=1835430302"